Study | Sex | Family history | Age (year) | PRS | Weighted PRS | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n (%) | CRCGEN n (%) | COLSCREEN n (%) | Female n (%) | Yesa n (%) | Min | Mean (SD) | Max | Min | Mean (SD) | Max | Min | Mean (SD) | Max | |
Population control | 1008 (28) | 864 (48) | 144 (8) | 467 (30) | 63 (20) | 19 | 64.2 (12.0) | 92 | 111 | 131.7 (7.2) | 156 | 5.7 | 7.3 (0.4) | 8.9 |
Screening control | 670 (19) | – | 670 (37) | 406 (26) | 48 (15) | 49 | 59.5 (6.0) | 70 | 111 | 131.5 (7.1) | 149 | 6.0 | 7.2 (0.4) | 8.7 |
LRL | 286 (8) | – | 286 (16) | 125 (8) | 24 (8) | 49 | 60.3 (5.7) | 71 | 110 | 131.8 (7.4) | 151 | 6.0 | 7.3 (0.5) | 8.4 |
IRL | 352 (10) | – | 352 (19) | 126 ()8 | 20 (6) | 49 | 59.8 (5.4) | 70 | 111 | 132.6 (7.0) | 151 | 6.0 | 7.4 (0.5) | 8.7 |
HRL | 226 (6) | – | 226 (12) | 65 (4) | 15 (5) | 50 | 60.6 (5.9) | 70 | 114 | 133.7 (7.4) | 150 | 6.2 | 7.4 (0.5) | 8.5 |
Screening CRC | 70 (2) | – | 70 (4) | 22 (1) | – | 50 | 61.1 (5.9) | 69 | 119 | 133.9 (6.4) | 150 | 6.5 | 7.3 (0.4) | 8.3 |
Clinically diagnosed CRC | 1007 (28) | 937 (52) | 70 (4) | 353 (23) | 146 (46) | 23 | 67.3 (11.0) | 91 | 110 | 134.5 (7.0) | 156 | 6.1 | 7.4 (0.4) | 8.9 |
Total | 3619 | 1801 (50) | 1818 (50) | 1564 (43) | 316 (9) | 19 | 63.1 (9.9) | 92 | 110 | 132.7 (7.2) | 156 | 5.7 | 7.3 (0.5) | 8.9 |